Clinical Trial Update: 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a 7-day combination therapy of vonoprazan, high-dose amoxicillin, and bismuth for Helicobacter pylori infection; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Bismuth subsalicylate (bismuth subsalicylate)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Helicobacter Pylori | Phase 4 | Status: RECRUITING